1. Augenstein, K. B., Ward, M. J., & Nelson, V. S. (1996). Spondyloepiphyseal dysplasia congenita with ventilator dependence: Two case reports. Archives of Physical Medicine and Rehabilitation, 77, 1201–1204.
2. Bannerman, R. M., Ingall, G. B., & Mohn, J. F. (1971). X-linked spondyloepiphyseal dysplasia tarda: Clinical and linkage data. Journal of Medical Genetics, 8, 291–301.
3. Chan, D., Taylor, T. K. F., & Cole, W. G. (1993). Characterization of an arginine 789 to cysteine substitution in alpha1(II) collagen chains of a patient with spondyloepiphyseal dysplasia. The Journal of Biological Chemistry, 268, 15238–15245.
4. Chan, D., Rogers, J. F., Bateman, J. F., et al. (1995). Recurrent substitutions of arginine 789 by cysteine in pro-alpha 1 (II) collagen chains produce spondyloepiphyseal dysplasia congenita. The Journal of Rheumatology. Supplement, 43, 37–38.
5. Choi, M. Y., Chan, C. C. Y., Chan, D., et al. (2009). Biochemical consequences of sedlin mutations that cause spondyloepiphyseal dysplasia tarda. Biochemical Journal, 423, 323–342.